AM-92016 hydrochloride

CAS No. 133229-11-5

AM-92016 hydrochloride( —— )

Catalog No. M20245 CAS No. 133229-11-5

AM-92016 is a specific blocker of rectifier potassium current. AM-92016 delays rectifier potassium channel and repolarizes the membrane thereby restricting the duration of the nerve impulse.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 50 In Stock
2MG 29 In Stock
5MG 46 In Stock
10MG 84 In Stock
25MG 159 In Stock
50MG 272 In Stock
100MG 390 In Stock
200MG 554 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AM-92016 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    AM-92016 is a specific blocker of rectifier potassium current. AM-92016 delays rectifier potassium channel and repolarizes the membrane thereby restricting the duration of the nerve impulse.
  • Description
    AM-92016 is a specific blocker of rectifier potassium current. AM-92016 delays rectifier potassium channel and repolarizes the membrane thereby restricting the duration of the nerve impulse.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    rectifier potassium current
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    133229-11-5
  • Formula Weight
    483.84
  • Molecular Formula
    C19H24Cl2N2O4S.HCl
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 150 mg/mL (310.02 mM)
  • SMILES
    Cl.CN(CCc1ccc(Cl)c(Cl)c1)CC(O)COc1ccc(NS(C)(=O)=O)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Connors SPet al.Actions and mechanisms of action of novel analogues of sotalol on guinea-pig and rabbitventricular cells. Br J Pharmacol. 1992 Aug;106(4):958-65.
molnova catalog
related products
  • BMS-813160

    BMS-813160 is the first dual?CCR2/CCR5?antagonist to enter Clinical development for cardiovascular.

  • Linoleoyl glycine

    Linoleoyl glycine, a modified polyunsaturated fatty acid, is an endogenous homologue of linoleoyl glycine. Linoleoyl glycine activates human KCNQ1/KCNE1 (hKCNQ1/hKCNE1) channels expressed in xenopus oocytes from mammalian skin.

  • Rabeprazole

    Rabeprazole (LY307640) is an H+/K+-ATPase inhibitor that inhibits cell proliferation in gastric epithelial cells by targeting STAT3-mediated glycolysis and can be used in the study of gastric ulcers.